| abstract |
The present invention relates to a monoclonal antibody that binds to a cytotoxic T lymphocyte antigen 4, a pharmaceutical composition comprising said antibody or fragment, a cell line producing said antibody or fragment, a method for producing said antibody or fragment, an isolated nucleic acid encoding a heavy and / or light chain presented herein an antibody or fragment, host cells comprising said isolated nucleic acid or fragment, using said antibody or fragment, optionally in combination with cells expressing granulocyte-macrophage colony stimulating factor, for the preparation of a medicament. |